Murdock Hunter R., General Counsel of Axsome Therapeutics Inc. ($AXSM), sold common shares on the open market five times over the last year for a total of $3.65 million. His most recent $AXSM stock sale occurred on June 23, 2025. These insider sales rank 2,375th among 11,678 individuals in our database, compared to an average of $8.59 million per insider across about 6.4 transactions. Murdock Hunter R. reported no open market purchases in the past 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 26, 2026 | Axsome Therapeutics, Inc. | $AXSM | Murdock Hunter R. | General Counsel | A | Restricted Stock Units | 16385 | $0.00 | 16,385.0000 | 50,412,640 | 9999.99% | 0.03% |
| June 20, 2025 | Axsome Therapeutics, Inc. | $AXSM | Murdock Hunter R. | General Counsel | S | Common Stock | 7500 | $102.47 | 0.0000 | 48,765,403 | 100.00% | 0.02% |
| June 23, 2025 | Axsome Therapeutics, Inc. | $AXSM | Murdock Hunter R. | General Counsel | M | Common Stock | 6014 | $29.91 | 6,014.0000 | 48,765,403 | 9999.99% | 0.01% |
| June 23, 2025 | Axsome Therapeutics, Inc. | $AXSM | Murdock Hunter R. | General Counsel | S | Common Stock | 6014 | $100.12 | 0.0000 | 48,765,403 | 100.00% | 0.01% |
| June 20, 2025 | Axsome Therapeutics, Inc. | $AXSM | Murdock Hunter R. | General Counsel | M | Stock Option (Right to Buy) | 7500 | $0.00 | 22,383.0000 | 48,765,403 | 25.10% | 0.02% |
| June 23, 2025 | Axsome Therapeutics, Inc. | $AXSM | Murdock Hunter R. | General Counsel | M | Stock Option (Right to Buy) | 6014 | $0.00 | 16,369.0000 | 48,765,403 | 26.87% | 0.01% |
| June 20, 2025 | Axsome Therapeutics, Inc. | $AXSM | Murdock Hunter R. | General Counsel | M | Common Stock | 7500 | $29.91 | 7,500.0000 | 48,765,403 | 9999.99% | 0.02% |
| June 16, 2025 | Axsome Therapeutics, Inc. | $AXSM | Murdock Hunter R. | General Counsel | S | Common Stock | 7500 | $102.42 | 0.0000 | 48,765,403 | 100.00% | 0.02% |
| June 17, 2025 | Axsome Therapeutics, Inc. | $AXSM | Murdock Hunter R. | General Counsel | M | Common Stock | 7500 | $29.91 | 7,500.0000 | 48,765,403 | 9999.99% | 0.02% |
| June 17, 2025 | Axsome Therapeutics, Inc. | $AXSM | Murdock Hunter R. | General Counsel | S | Common Stock | 7500 | $100.26 | 0.0000 | 48,765,403 | 100.00% | 0.02% |
| June 18, 2025 | Axsome Therapeutics, Inc. | $AXSM | Murdock Hunter R. | General Counsel | M | Common Stock | 7500 | $29.91 | 7,500.0000 | 48,765,403 | 9999.99% | 0.02% |
| June 18, 2025 | Axsome Therapeutics, Inc. | $AXSM | Murdock Hunter R. | General Counsel | S | Common Stock | 7500 | $100.90 | 0.0000 | 48,765,403 | 100.00% | 0.02% |
| June 16, 2025 | Axsome Therapeutics, Inc. | $AXSM | Murdock Hunter R. | General Counsel | M | Stock Option (Right to Buy) | 7500 | $0.00 | 44,883.0000 | 48,765,403 | 14.32% | 0.02% |
| June 17, 2025 | Axsome Therapeutics, Inc. | $AXSM | Murdock Hunter R. | General Counsel | M | Stock Option (Right to Buy) | 7500 | $0.00 | 37,383.0000 | 48,765,403 | 16.71% | 0.02% |
| June 18, 2025 | Axsome Therapeutics, Inc. | $AXSM | Murdock Hunter R. | General Counsel | M | Stock Option (Right to Buy) | 7500 | $0.00 | 29,883.0000 | 48,765,403 | 20.06% | 0.02% |
| June 16, 2025 | Axsome Therapeutics, Inc. | $AXSM | Murdock Hunter R. | General Counsel | M | Common Stock | 7500 | $29.91 | 7,500.0000 | 48,765,403 | 9999.99% | 0.02% |
| Feb. 21, 2025 | Axsome Therapeutics, Inc. | $AXSM | Murdock Hunter R. | General Counsel | A | Restricted Stock Units | 7740 | $0.00 | 7,740.0000 | 48,765,403 | 9999.99% | 0.02% |
| Feb. 21, 2025 | Axsome Therapeutics, Inc. | $AXSM | Murdock Hunter R. | General Counsel | A | Employee Stock Option (Right to Buy) | 7816 | $0.00 | 7,816.0000 | 48,765,403 | 9999.99% | 0.02% |
| Feb. 24, 2025 | Axsome Therapeutics, Inc. | $AXSM | Murdock Hunter R. | General Counsel | A | Performance Stock Units | 7740 | $0.00 | 7,740.0000 | 48,765,403 | 9999.99% | 0.02% |
| Feb. 27, 2024 | Axsome Therapeutics, Inc. | $AXSM | Murdock Hunter R. | General Counsel | A | Restricted Stock Units | 12956 | $0.00 | 12,956.0000 | 0 | 9999.99% | 0.00% |
| Feb. 27, 2024 | Axsome Therapeutics, Inc. | $AXSM | Murdock Hunter R. | General Counsel | A | Employee Stock Option (Right to Buy) | 23593 | $0.00 | 23,593.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2023 | Axsome Therapeutics, Inc. | $AXSM | Murdock Hunter R. | General Counsel | A | Restricted Stock Units | 16883 | $0.00 | 16,883.0000 | 0 | 9999.99% | 0.00% |
| March 2, 2023 | Axsome Therapeutics, Inc. | $AXSM | Murdock Hunter R. | General Counsel | A | Employee Stock Option (Right to Buy) | 29773 | $0.00 | 29,773.0000 | 0 | 9999.99% | 0.00% |